TrialNature medicine2022

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.

Miranda Gogishvili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.